BOOSTER SHOT: More Covishield, Covaxin and Sputnik vaccine manufacturing plants coming! Bharat Biotech, Serum Institute to set up new units

In order to ramp up the Coronavirus vaccination process in the country, the government is planning to produce Oxford-AstraZeneca’s Covishield, Bharat Biotech’s Covaxin and Sputnik vaccines through 'more and more' manufacturing plants in India.   

In the latest development, Sputnik has tied up with a number of companies in India to manufacture the coronavirus vaccine. Bharat Biotech and Serum Institute of India (SII) are setting up new plants to develop the Covid-19 vaccines.   

Taking to Twitter on Saturday, May 15, AIIMS chief Dr Randeep Guleria said that by the months of July and August, we would have a large volume of Covid-19 doses available.

See Zee Business Live TV Streaming Below:

Sputnik V coronavirus vaccine has already arrived in India and is expected to be available in the market by the next week. Currently, India is battling the second wave of the Covid-19 pandemic.   

Although, the vaccination drive has already started in India still a considerable portion of the population is yet to get vaccinated.

Covishield, Covaxin, Sputnik will be manufactured in India by more & more manufacturing plants. Sputnik has tied up with no.of companies in India to manufacture. New plants being set up by Bharat Biotech&SII. By July-Aug we'll have large no.of doses available: Dr Randeep Guleria

— ANI (@ANI) May 15, 2021

Along with Covaxin and Covishield, the availability of Sputnik V from Russia, which is the third Covid-19 vaccine to be available in India, will be a booster dose for the current Covid-19 vaccination drive in the country.

Indian pharma company Dr Reddy’s Laboratories has in-licensed Russia’s Covid-19 vaccine and rolled out Sputnik V in the local market on Friday, 14 May. The imported doses of the vaccine are currently priced at Rs 995.40 per dose, with the possibility of a lower price point when the local supply will start.